Flu Vaccine Testimony: MedImmune's View


Now that Chiron Corp.'s Fluvirin will not be available for the 2004-2005 flu season, MedImmune, Inc., maker of FluMist, takes on a major role in the nation's flu preparedness. In early 2004, Dr. Jim Young, the firm's president of R&D, testified before the U.S. House of Representatives about what MedImmune can do.


Author: Dr. Jim Young, MedImmune

Find more white papers on Process OperationsIndustry Developments

View all white papers»